India is eyeing the Oxford-AstraZeneca vaccine candidate as the likely first shot against Covid-19 to be available for Indians by end of 2020, while locally developed candidates are also being watched closely as it is felt that they may also enter the market with a gap of few weeks if cleared in trials, officials said.
from Times of India https://ift.tt/3kYSB2M
via
India eyeing Oxford's Covid vaccine AstraZeneca
Related Posts:
It’s for Parliament to rein in partisan Speakers: Supreme CourtThe Supreme Court on Thursday said it was for Parliament to legislate and provide a timeframe for adjudication of disqualification petitions against legislators by Speakers, who of late have adopted a partisan approach to kee… Read More
HC: JJ Act inadequate for crimes by under-16sThe Indore bench of the Madhya Pradesh high court has observed that the present law dealing with children aged below 16 in heinous-crime cases as juvenile offenders is "totally inadequate and ill equipped". The court also ma… Read More
Switzerland, Iceland, 7 EU nations approve Covishield for travel entrySwitzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under mandatory quarantine. from T… Read More
SC entertains PIL seeking ‘protection of Hindus in West Bengal’The Supreme Court on Thursday sought responses from the Centre, the West Bengal government and the Election Commission on a PIL which sought protection of Hindus, their property and identity in the wake of alleged post-poll v… Read More
Zydus seeks nod for world’s first plasmid DNA Covid vaccineHomegrown healthcare and pharmaceutical major Zydus Cadila has applied for emergency use authorisation (EUA) to the office of the Drug Controller General of India for ZyCoV-D, its plasmid DNA vaccine against Covid-19. from … Read More
0 Comments:
Post a Comment